Company news

Share this article:

Prescribing Reference, Inc. said more than 50,000 healthcare professionals have downloaded its eMPR desktop and mobile version of MPR drug databases, and announced a promotion whereby new registrants will be entered into a raffle to win their choice of a MacBook or Tablet PC, iPhone or SmartPhone. The winner will be announced in June. Prescribing Reference's parent, Haymarket, publishes MM&M.

Alkermes announced that it is restructuring its operations following the termination by Eli Lilly of the AIR Insulin program. With the restructuring, Alkermes is reducing its workforce by approximately 150 employees and closing its AIR commercial manufacturing facility in Chelsea, MA. The company is taking these actions based on its current expectations of the financial impact of Lilly's termination of the AIR Insulin program. The reduction in workforce, effective this week, represents approximately 18% of the company's total workforce.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.